Susquehanna International Group, LLP Lexicon Pharmaceuticals, Inc. Transaction History

Susquehanna International Group, LLP

$568 Billion
Q1 2024

A detailed history of Susquehanna International Group, LLP transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 10,843 shares of LXRX stock, worth $17,348. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,843

Previous 417,813 97.4%

Holding current value

$17,348

Previous $639,000 95.93%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	SELL	$1.3 - $3.58 $529,061 - $1.46 Million	-406,970 Reduced 97.4%	10,843 $26,000
Q4 2023 Feb 14, 2024	BUY	$1.0 - $1.53 $89,307 - $136,639	89,307 Added 27.19%	417,813 $639,000
Q3 2023 Nov 14, 2023	SELL	$1.06 - $2.33 $7,368 - $16,195	-6,951 Reduced 2.07%	328,506 $358,000
Q2 2023 Aug 11, 2023	BUY	$2.15 - $3.49 $606,652 - $984,752	282,164 Added 529.46%	335,457 $768,000
Q1 2023 May 16, 2023	BUY	$1.99 - $2.68 $8,831 - $11,893	4,438 Added 9.08%	53,293 $129,000

Q4 2022 Feb 14, 2023	SELL	$1.8 - $2.56 $54,894 - $78,072	-30,497 Reduced 38.43%	48,855 $93,000
Q3 2022 Nov 14, 2022	SELL	$1.94 - $3.43 $28,322 - $50,074	-14,599 Reduced 15.54%	79,352 $190,000
Q2 2022 Aug 15, 2022	SELL	$1.31 - $2.69 $28,762 - $59,061	-21,956 Reduced 18.94%	93,951 $175,000
Q1 2022 May 16, 2022	SELL	$1.95 - $3.89 $38,744 - $77,290	-19,869 Reduced 14.63%	115,907 $242,000
Q4 2021 Feb 14, 2022	BUY	$3.81 - $6.16 $16,866 - $27,270	4,427 Added 3.37%	135,776 $535,000
Q3 2021 Nov 15, 2021	BUY	$3.38 - $5.35 $310,192 - $490,985	91,773 Added 231.89%	131,349 $632,000
Q2 2021 Aug 11, 2021	SELL	$4.12 - $5.87 $206,906 - $294,791	-50,220 Reduced 55.93%	39,576 $182,000
Q4 2020 Feb 16, 2021	BUY	$1.05 - $3.67 $35,021 - $122,409	33,354 Added 59.09%	89,796 $307,000
Q2 2020 Aug 14, 2020	BUY	$1.75 - $2.3 $65,215 - $85,711	37,266 Added 194.34%	56,442 $113,000
Q1 2020 May 15, 2020	SELL	$1.8 - $4.28 $72,466 - $172,308	-40,259 Reduced 67.74%	19,176 $37,000
Q4 2019 Feb 14, 2020	BUY	$3.16 - $5.15 $127,373 - $207,586	40,308 Added 210.74%	59,435 $247,000
Q3 2019 Nov 14, 2019	SELL	$1.2 - $6.66 $15,570 - $86,413	-12,975 Reduced 40.42%	19,127 $58,000
Q2 2019 Aug 16, 2019	SELL	$5.35 - $7.11 $508,517 - $675,805	-95,050 Reduced 74.75%	32,102 $202,000
Q1 2019 May 15, 2019	BUY	$4.36 - $7.94 $129,378 - $235,611	29,674 Added 30.44%	127,152 $707,000
Q4 2018 Feb 14, 2019	BUY	$6.15 - $10.51 $391,183 - $668,509	63,607 Added 187.79%	97,478 $647,000
Q2 2018 Aug 14, 2018	BUY	$7.8 - $13.69 $106,610 - $187,114	13,668 Added 67.65%	33,871 $406,000
Q1 2018 May 15, 2018	SELL	$7.86 - $11.39 $269,275 - $390,210	-34,259 Reduced 62.9%	20,203 $173,000
Q4 2017 Feb 14, 2018	BUY	$8.77 - $12.28 $82,490 - $115,505	9,406 Added 20.88%	54,462 $538,000
Q3 2017 Nov 14, 2017	BUY	$12.17 - $16.3 $548,331 - $734,412	45,056	45,056 $554,000

Others Institutions Holding LXRX

# of Institutions

122

Shares Held

159M

Call Options Held

2.11M

Put Options Held

412K

View Full List

About LEXICON PHARMACEUTICALS, INC.

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $302M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

More about LXRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Lexicon Pharmaceuticals, Inc. Transaction History